Sponsor Pipeline

FengYan Jin Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06109233
A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple…
overall status: Recruiting → Unknown
Active Trials by Phase
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06946407 Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine… Primary Central Nervous System Lymphoma (PCNSL) Recruiting
NCT06099912 Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM Multiple Myeloma Recruiting
NCT06252792 Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma Multiple Myeloma Recruiting
NCT07045168 Risk-adapted Therapeutic Strategy in +1q NDMM Multiple Myeloma Not Yet Recruiting
Disease Areas
Get alerts when FengYan Jin's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free